Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: Correlates with disease activity

Genes and Immunity

Volumn 8, Issue 6, 2007, Pages 480-491

  Galligan, C L ^a,b   Baig, E ^a,b   Bykerk, V ^b,c   Keystone, E C ^b,c   Fish, E N ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Rebecca MacDonald Centre for Arthritis and Autoimmune Disease   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CLUSTERIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 64; GENE PRODUCT; GLYCOSYLTRANSFERASE; GLYCOSYLTRANSFERASE SIAT7E; GROWTH INHIBITOR; HLA DQ ANTIGEN; HOMEODOMAIN PROTEIN; INSULIN RECEPTOR KINASE; LECTIN RECEPTOR; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PREDNISONE; PROTEIN BAIAP2L; PROTEIN HAPLN1; PROTEIN MAB21L2; PROTEIN OSAP; RHEUMATOID FACTOR; SARCOGLYCAN; TRANSCRIPTION FACTOR HOXD10; TRANSCRIPTION FACTOR HOXD11; TRANSCRIPTION FACTOR HOXD13; TRANSCRIPTION FACTOR LHX2; TRANSCRIPTION FACTOR POU; TRANSCRIPTION FACTOR POU3F3; TRIPARTITE MOTIF PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SENSITIVITY; ERYTHROCYTE SEDIMENTATION RATE; FIBROBLAST; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC HETEROGENEITY; GENETIC RISK; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; HUMAN CELL; HUMAN TISSUE; JOINT INJURY; MICROANALYSIS; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SYNOVIUM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; JOINTS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS; QUESTIONNAIRES; RHEUMATOID FACTOR; SYNOVIAL MEMBRANE;

EID: 34548448091     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364400     Document Type: Article

References (50)

1. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001; 27: 269-281.
2. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358 903-911.
3. Firestein GS. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J Clin Rheumatol 2005; 11 (3 Suppl): S39-S44.
4. Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: A key player in inflammation and joint destruction. Clin Immunol 2005; 115: 118-128.
5. Melnyk VO, Shipley GD, Sternfeld MD, Sherman L, Rosenbaum JT. Synoviocytes synthesize, bind, and respond to basic fibroblast growth factor. Arthritis Rheum 1990; 33: 493-500.
6. Ota F, Maeshima A, Yamashita S, Ikeuchi H, Kaneko Y, Kuroiwa T et al. Activin A induces cell proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum 2003; 48: 2442-2449.
7. Lindberg J, Af Klint E, Ulfgren AK, Stark A, Andersson T, Nilsson P et al. Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology. Arthritis Res Ther 2006; 8: R47.
8. Ruschpler P, Lorenz P, Eichler W, Koczan D, Hanel C, Scholz R et al. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther 2003; 5: R241-R252.
9. Szodoray P, Alex P, Frank MB, Turner M, Turner S, Knowlton N et al. A genome-scale assessment of peripheral blood B-cell molecular homeostasis in patients with rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 1466-1476.
10. Bovin LF, Rieneck K, Workman C, Nielsen H, Sorensen SF, Skjodt H et al. Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor. Immunol Lett 2004; 93: 217-226.
11. Kasperkovitz PV, Timmer TC, Smeets TJ, Verbeet NL, Tak PP, van Baarsen LG et al. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum 2005; 52: 430-441.
12. Taberner M, Scott KF, Weininger L, Mackay CR, Rolph MS. Overlapping gene expression profiles in rheumatoid fibroblast-like synoviocytes induced by the proinflammatory cytokines interleukin-1 beta and tumor necrosis factor. Inflamm Res 2005; 54: 10-16.
13. Spurrell DR, Oldford SA, Frost T, Larsen B, Codner D, Edgecombe A et al. Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes. Hum Immunol 2004; 65: 1516-1529.
14. Haringman JJ, Smeets TJ, Reinders-Blankert P, Tak PP. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis 2006; 65 294-300.
15. Lee BO, Ishihara K, Denno K, Kobune Y, Itoh M, Muraoka O. et al. Elevated levels of the soluble form of bone marrow stromal cell antigen 1 in the sera of patients with severe rheumatoid arthritis. Arthritis Rheum, 1996, 39: 629-637.
16. Devauchelle V, Marion S, Cagnard N, Mistou S, Falgarone G, Breban M et al. DNA microarray allows molecular profiling or rheumatoid arthritis and identification of pathophysiological targets. Genes Immunol 2004; 5: 597-608.
17. Paulsen F, Pufe T, Conradi L, Varoga D, Tsokos M, Papendieck J et al. Antimicrobial peptides are expressee and produced in healthy and inflamed human synovial membranes. J Pathol 2002; 198: 369-377.
18. van der Pouw Kraan TC, van Gaalen FA, Huizinga TW, Pieterman E, Breedveld FC, Verweij CL. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immunol 2003; 4: 187-196.
19. van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC et al. Rheumatoid arthritis is a heterogeneous disease: Evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 2003; 48 2132-2145.
20. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001; 19: 163-196.
21. Steenvoorden MM, Tolboom TC, van der Pluijm G, Lowik C, Visser CP, DeGroot J et al. Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics. Arthritis Res Ther 2006; 8: R165.
22. Mattey DL, Dawes PT, Nixon NB, Slater H. Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: Modulation by basic fibroblast growth factor. Ann Rheum Dis 1997; 56: 426-431.
23. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003; 171: 380-389.
24. Goodman FR. Limb malformations and the human HOX genes. Am J Med Genet 2002; 112: 256-265.
25. Richter K, Wirta V, Dahl L, Bruce S, Lundeberg J, Carlsson L et al. Global gene expression analyses of hematopoietic stem cell-like cell lines with inducible Lhx2 expression. BMC Genomics 2006; 7: 75.
26. Rhee H, Polak L, Fuchs E. Lhx2 maintains stem cell character in hair follicles. Science 2006; 312: 1946-1949.
27. Salsi V, Zappavigna V. Hoxd13 and Hoxa13 directly control the expression of the EphA7 Ephrin tyrosine kinase receptor in developing limbs. J Biol Chem 2006; 281: 1992-1999.
28. Nguyen NC, Hirose T, Nakazawa M, Kobata T, Nakamura H, Nishioka K et al. Expression of HOXD9 in fibroblast-like synoviocytes from rheumatoid arthritis patients. Int J Mol Med 2002; 10: 41-48.
29. Khoa ND, Nakazawa M, Hasunuma T, Nakajima T, Nakamura H, Kobata T et al. Potential role of HOXD9 in synoviocyte proliferation. Arthritis Rheum 2001; 44: 1013-1021.
30. Fowler Jr MJ, Neff MS, Borghaei RC, Pease EA, Mochan E, Thornton RD. Induction of bone morphogenetic protein-2 by interleukin-1 in human fibroblasts. Biochem Biophys Res Commun 1998; 248: 450-453.
31. Lories RJ, Derese I, Ceuppens JL, Luyten FP. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 2003; 48: 2807-2818.
32. Cheon H, Boyle DL, Firestein CS. Wnt1 inducible signaling pathway protein-3 regulation and microsatellite structure in arthritis. J Rheumatol 2004; 31: 2106-2114.
33. Gu J, Marker-Hermann E, Baeten D, Tsai WC, Gladman D, Xiong M et al. A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. Rheumatology (Oxford) 2002; 41: 759-766.
34. Sivas F, Barea N, Onder M, Ozoran K. The relation between joint erosion and generalized osteoporosis and disease activity in patients with rheumatoid arthritis. Rheumatol Int 2006; 26: 896-899.
35. Mahmoud RK, El-Ansary AK, El-Eishi HH, Kamal HM, El-Saeed NH. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis. Ital J Biochem 2005; 54: 248-257.
36. Baldessari D, Badaloni A, Longhi R, Zappavigna V, Consalez GG. MAB21L2, a vertebrate member of the male-abnormal 21 family, modulates BMP signaling and interacts with SMAD1. BMC Cell Biol 2004; 5: 48.
37. Watanabe H, Yamada Y. Mice lacking link protein develop dwarfism and craniofacial abnormalities. Nat Genet 1999; 21: 225-229.
38. Lorenz P, Ruschpler P, Koczan D, Stiehl P, Thiesen HJ. From transcriptome to proteome: Differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies. Proteomics 2003; 3: 991-1002.
39. Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 2001; 108: 1781-1788.
40. Samad TA, Rebbapragada A, Bell E, Zhang Y, Sidis Y, Jeong SJ et al. DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem 2005; 280: 14122-14129.
41. Rockett JC. Genomic and proteomic techniques applied to reproductive biology. Genome Biol 2001; 2: REPORTS4020.
42. Hock BD, O'Donnell JL, Taylor K, Steinkasserer A, McKenzie JL, Rothwell AG et al. Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients. Tissue Antigens 2006; 67: 57-60.
43. Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ et al. BLyS and APRIL in rheumatoid arthritis. J Clin Invest 2005; 115: 3083-3092.
44. Ruth JH, Haas CS, Park CC, Amin MA, Martinez RJ, Haines III GK et al. CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum 2006; 54: 765-778.
45. Hietala MA, Nandakumar KS, Persson L, Fahlen S, Holmdahl R, Pekna M. Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur J Immunol 2004; 34: 1208-1216.
46. Kraan MC, Reece RJ, Barg EC, Smeets TJ, Farnell J, Rosenburg R et al. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers. Arthritis Rheum 2000; 43: 1820-1830.
47. Conn DL, Lim SS. New role for an old friend: Prednisone is a disease-modifying agent in early rheumatoid arthritis. Curr Opin Rheumatol 2003; 15: 193-196.
48. Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA et al. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 1994; 37: 992-999.
49. Gerlag DM, Haringman JJ, Smeets TJ, Zwinderman AH, Kraan MC, Laud PJ et al. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis Rheum 2004; 50: 3783-3791.
50. Lee L, Liu J, Manuel J, Gorczynski RM. A role for the immunomodulatory molecules CD200 and CD200R in regulating bone formation. Immunol Lett 2006; 105: 150-158.